Morepen Laboratories Ltd reported a 117% year-on-year increase in profit after tax (PAT) to ₹89 crore for Q2 FY27, driven by the scale-up of contract development and manufacturing organisation (CDMO) supplies, improving business mix and higher operating leverage. Revenue rose 81% to ₹755 crore in the quarter ended September 30, 2026. EBITDA surged 273% year-on-year […]